Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-14, Stock:JNJ, The news for the past five days is as follows:
2020-02-07: NEWS1: Our Favorite Dividend ETF.NEWS2: Coronavirus update: Business impact widens as China fights to get infections under control.NEWS3: Why a Harvard professor is asking shareholders to vote away their right to sue.NEWS4: With Alibaba Stock the Waiting Is the Hardest Part.NEWS5: AbbVie's (ABBV) Q4 Earnings Beat, 2020 View Solid, Stock Up.NEWS6: T. Rowe Price Keeps Buying Fox, General Electric.NEWS7: Johnson & Johnson Hit with $750M Punitive Damages Verdict for Failing to Warn about Cancer-Causing Asbestos in Talc Products.NEWS8: Can JNJ Stock Keep on Its Current Growth Track?.NEWS9: Breaking: J&J to Pay $750M in Baby Powder Case.NEWS10: Stocks - U.S. Futures Point Lower; Caution Sets in Ahead of Payrolls.NEWS11: Outsmarting a Killer: Georgia inventors, researchers finding new tech to tackle heart disease.
2020-02-10: NEWS1: New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA.NEWS2: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.
2020-02-11: NEWS1: Releasing Quarantined Americans; Cruise Concerns: Virus Update.NEWS2: J&J partners with U.S. agency to develop coronavirus vaccine.NEWS3: Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine.NEWS4: J&J Files Application for Darzalex Label Expansion With FDA.NEWS5: The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology.
2020-02-12: NEWS1: Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference.NEWS2: China Keeps Experts Waiting; Conference Canceled: Virus Update.NEWS3: Buy AbbVie for its Growth Prospects, Yield and Low Valuation.NEWS4: J&J (JNJ) Signs Deal With HHS to Develop Coronavirus Vaccine.NEWS5: The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data.NEWS6: This Medical Giant Is Lingering In A Buy Zone — Are Shares A Good Bet?.
2020-02-13: NEWS1: Dow Jones Today: Coronavirus Controversy Reemerges.NEWS2: 3 Dow Jones Industrial Average Stocks to Sell.

Answer: Rise